The latest price target for Imunon (NASDAQ:IMNN) was reported by D. Boral Capital on May 19, 2025. The analyst firm set a price target for $0.00 expecting IMNN to fall to within 12 months (a possible -100.00% downside). 19 analyst firms have reported ratings in the last year.

The latest analyst rating for Imunon (NASDAQ:IMNN) was provided by D. Boral Capital, and Imunon downgraded their hold rating.

There is no last upgrade for Imunon

The last downgrade for Imunon Inc happened on May 19, 2025 when D. Boral Capital changed their price target from N/A to N/A for Imunon Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Imunon, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Imunon was filed on May 19, 2025 so you should expect the next rating to be made available sometime around May 19, 2026.

While ratings are subjective and will change, the latest Imunon (IMNN) rating was a downgraded with a price target of $0.00 to $0.00. The current price Imunon (IMNN) is trading at is $1.00, which is out of the analyst’s predicted range.